Advertisement

Journal of Nuclear Cardiology

, Volume 17, Issue 5, pp 928–933 | Cite as

Very late drug-eluting stent thrombosis post-exercise myocardial perfusion SPECT

  • A. Dos SantosEmail author
  • J. D. Peirano
  • M. J. Bastianello
  • R. O. Calviño
Nuclear Cardiology Bullet

Case report

A 66-year-old man was admitted at the hospital because of the acute-onset of moderate intensity chest pain associated with new ECG abnormalities.

The patient had a history of hypertension and overweight. Five years before, he suffered an anterior non-ST segment elevation myocardial infarction. Coronary angiography showed a 90% stenosis in middle left anterior descending coronary artery (LAD), with no significant disease in the other vessels. Percutaneous coronary intervention (PCI) with implantation of a Bare Metal Stent (BMS) was performed at that time. Aspirin, clopidogrel, atenolol and sinvastatin were prescribed. Ten months after his first intervention, he developed severe intrastent restenosis and a Paclitaxel-eluting stent (DES) (Taxus® Boston Scientific) was successfully implanted. The patient underwent asymptomatic thereafter and Clopidogrel was discontinued after 12 months of treatment. Two years after the DES implantation, a Technetium-99m-sestamibi...

Keywords

Percutaneous Coronary Intervention Clopidogrel Leave Anterior Descend Stent Thrombosis Perindopril 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Supplementary material

12350_2010_9194_MOESM1_ESM.avi (2 mb)
Supplementary material 1 (AVI 2050 kb)

Supplementary material 2 (AVI 3102 kb)

12350_2010_9194_MOESM3_ESM.avi (2 mb)
Supplementary material 3 (AVI 2050 kb)

Supplementary material 4 (AVI 3102 kb)

References

  1. 1.
    Bavry AA, Kumbhani DJ, Helton T, Borek P, Mood G, Bhatt D. Late thrombosis of drug-eluting stents: A meta-analysis of randomised clinical trials. Am J Med 2006;119:1056-61CrossRefPubMedGoogle Scholar
  2. 2.
    Wenaweser P, Daemen J, Zwahlen M, van Domburg R, Jüni P, Vaina S, et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. J Am Coll Cardiol 2008;52:1134-40CrossRefPubMedGoogle Scholar
  3. 3.
    Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, et al. Safety and efficacy of sirolimus and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008CrossRefPubMedGoogle Scholar
  4. 4.
    Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: An autopsy study. Circulation 2008;118:1138-45CrossRefPubMedGoogle Scholar
  5. 5.
    Cook S, Ladich E, Nakazawa G, Eshtehardi P, Neidhart M, Vogel R, et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation 2009;120:391-9CrossRefPubMedGoogle Scholar
  6. 6.
    Zellweger MJ, Weinbacher M, Zutter AW, Jeger RV, Mueller-Brand J, Kaiser C, et al. Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting. J Am Coll Cardiol 2003;42:33-40CrossRefPubMedGoogle Scholar
  7. 7.
    Zellweger MJ, Kaiser C, Brunner-La Rocca HP, Buser PT, Osswald S, Weiss P, et al. Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation. J Nucl Med 2008;49:550-6CrossRefPubMedGoogle Scholar
  8. 8.
    ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009. Appropriate use criteria for cardiac radionuclide imaging. J Am Coll Cardiol 2009;53:2201-29Google Scholar
  9. 9.
    Oqueli E, Hiscock M, Dick R. Very late drug-eluting stent thrombosis post exercise stress echocardiogram. Heart Lung Circ 2008;17S:S21-5CrossRefGoogle Scholar
  10. 10.
    Cinza-Rey R, Moreno R, Macaya E. Very late Taxus stent thrombosis and symptom-limited exercise testing. Rev Esp Cardiol 2008;61:327-33Google Scholar
  11. 11.
    Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, et al. ACC/AHA 2002 guideline update for exercise testing—summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002;106:1883-92CrossRefPubMedGoogle Scholar
  12. 12.
    Montgomery HE, Clarkson P, Nwose OM, Mikailidis DP, Jagroop IA, Dollery C, et al. The acute rise in plasma fibrinogen concentration with exercise is influenced by the G-453-A polymorphism of the b-fibrinogen gene. Arterioscler Thromb Vasc Biol 1996;16:386-91PubMedGoogle Scholar
  13. 13.
    Herren T, Bärtsch P, Haeberli A, Straub PW. Increased thrombinantithrombin III complexes after 1 h of physical exercise. J Appl Physiol 1992;73:2499-504PubMedGoogle Scholar
  14. 14.
    Kestin AS, Ellis PA, Barnard MR, Errichetti A, Rosner B, Michelson AD. Effect of strenuous exercise on platelet activation state and reactivity. Circulation 1993;88:1502-11PubMedGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2010

Authors and Affiliations

  • A. Dos Santos
    • 1
    Email author
  • J. D. Peirano
    • 1
  • M. J. Bastianello
    • 1
  • R. O. Calviño
    • 2
  1. 1.Department of Nuclear MedicineSanatorio Mater DeiCiudad Autónoma de Buenos AiresArgentina
  2. 2.Department of CardiologySanatorio Mater DeiCiudad Autónoma de Buenos AiresArgentina

Personalised recommendations